Eosinophilic pneumonia historical perspective: Difference between revisions

Pneumonia Main Page
	Eosinophilic pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Eosinophilic pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Eosinophilic pneumonia historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Eosinophilic pneumonia historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Eosinophilic pneumonia historical perspective
CDC onEosinophilic pneumonia historical perspective
Eosinophilic pneumonia historical perspective in the news
Blogs on Eosinophilic pneumonia historical perspective
Directions to Hospitals Treating Eosinophilic pneumonia
Risk calculators and risk factors for Eosinophilic pneumonia historical perspective

Revision as of 20:53, 10 February 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Priyamvada Singh, M.D. [2]

At the turn of the 20th century, it was recognized that some patients died with bilateral lung disease that was unrelated to the common nontraumatic causes of death at that time.
At autopsy, the lungs were cystic and scarring process preferentially involved the peripheral aspects of the lungs and named the honeycomb changes.

In 1944, Hamman described a group of four otherwise healthy patients who developed rapid and fulminantly progressive lung disease, and died of respiratory failure within 1 to 3 months of presentation. At autopsy, these patients had advanced honeycomb changes and fibrosis in their lungs. This disorder became known as Hamman-Rich syndrome.

In 1969, Carrington was the first to describe eosinophilic pneumonia and known as Carrington syndrome.
In 1989, Acute eosinophilic pneumonia was first described.

@@ Line 4: / Line 4: @@
 ==Overview==
-Chronic eosinophilic pneumonia was first described by Carrington in [[1969]], and it is also known as '''Carrington syndrome'''. Prior to that, eosinophilic pneumonia was a well described pathologic entity usually associated with medication or parasite exposures. Acute eosinophilic pneumonia was first described in [[1989]]{{ref|Badesch}}{{ref|Allen}}.
+* At the turn of the 20th century, it was recognized that some patients died with bilateral lung disease that was unrelated to the common nontraumatic causes of death at that time.
+* At autopsy, the lungs were cystic and scarring process preferentially involved the peripheral aspects of the lungs and named the honeycomb changes.
-==Historical Perspective
+* In 1944, Hamman described a group of four otherwise healthy patients who developed rapid and fulminantly progressive lung disease, and died of respiratory failure within 1 to 3 months of presentation.  At autopsy, these patients had advanced honeycomb changes and fibrosis in their lungs. This disorder became known as '''''Hamman-Rich syndrome'''''.
+* In [[1969]], Carrington was the first to describe eosinophilic pneumonia and known as '''''Carrington syndrome'''.''
+* In [[1989]], Acute eosinophilic pneumonia was first described.
 ==References==